22 February 2023 Scandion Oncology – Q4 & year-end report 2022 Download Presentation Webcast Workbook
19 January 2023 Scandion Oncology A/S: Scandion Oncology receives favorable opinion from the European Patent Office on Composition of Matter Patent-application for lead compound SCO-101 Download Presentation Webcast Workbook
1 December 2022 Scandion Oncology appoints Francois Martelet, M.D., as new Chief Executive Officer Download Presentation Webcast Workbook
28 October 2022 Scandion Oncology Announces Results of Extraordinary General Meeting Download Presentation Webcast Workbook
13 October 2022 Scandion Oncology – Notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
30 September 2022 Scandion Oncology announce topline results from part 2 of the CORIST phase II trial Download Presentation Webcast Workbook
31 August 2022 Bo Rode Hansen is leaving the position as President and CEO of Scandion Oncology Download Presentation Webcast Workbook
30 August 2022 Scandion Oncology announce change to its Executive Management Download Presentation Webcast Workbook
17 August 2022 Scandion Oncology extends PANTAX trial due to better-than-expected tolerability of SCO-101 Download Presentation Webcast Workbook
1 July 2022 Scandion Oncology announces preliminary outcome of its rights issue Download Presentation Webcast Workbook